ArticleFrontiers in neuroscience2026
Dual-graph attention autoencoder for spatial domain identification in ischemic stroke.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Spatial transcriptomics enables molecular mapping of ischemic stroke tissue, but spatial domain identification is challenging when injury disrupts normal tissue geometry. Methods relying on a single spatial-proximity graph cannot connect physically distant spots that share damage-associated transcriptional programs. Methods: We developed SpatialDomainAE, an unsupervised dual-graph attention autoencoder that constructs separate spatial-neighbor and expression-similarity graphs, processes each using graph attention, and combines their embeddings through learned per-spot fusion weights. The method was evaluated on a mouse middle cerebral artery occlusion 10× Visium dataset comprising control, 1-, 3-, and 7-day post-injury sections, totaling 10,173 spots and 22 annotated domains. All methods were evaluated over 10 random seeds using a shared Leiden-resolution protocol. Results: At 3 days post-injury, SpatialDomainAE achieved an ARI of 0.700 ± 0.025 and significantly exceeded all external baselines, including the dual-view Spatial-MGCN. Across all four samples, its performance was competitive rather than uniformly superior, and it was robust under a fixed clustering resolution. No comparable advantage was observed on an external human dorsolateral prefrontal cortex benchmark. Controlled experiments showed that the long-range transcriptomic content of the feature graph, rather than edge length alone, accounted for the improvement. Fusion weights separated lesion-associated domains at the region level, while differential expression and pathway enrichment recovered inflammatory, complement, gliosis, and proliferative programs. Discussion: SpatialDomainAE is particularly useful in disrupted pathological tissue. Its fusion weights should be interpreted as an exploratory region-level model diagnostic rather than a validated spot-level biomarker.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.